Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fc Global Realty Inc (FCRE)

Fc Global Realty Inc (FCRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fc Global Realty Inc 15150 North Hayden Road Suite 235 Scottsdale AZ 85260 USA

www.gadsdenreit.com P: 215-813-1430

Description:

Photomedex, Inc. develops, manufactures and markets therapeutic excimer laser-based instrumentation designed to treat psoriasis and vitiligo. They are also developing their technology for the treatment of other skin disorders. They've received the first Food and Drug Administration, or FDA, approval to market an excimer laser system, XTRAC system, for the treatment of psoriasis. They have commercially launched the XTRAC system in the United States.

Key Statistics

Overview:

Market Capitalization, $K 38,871
Shares Outstanding, K 389,104
Annual Sales, $ 40 K
Annual Net Income, $ -2,040 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -2,810 K
60-Month Beta 2.31
% of Insider Shareholders 5.04%
% of Institutional Shareholders 0.00%
Float, K 369,493
% Float 94.96%

Growth:

1-Year Return -59.31%
3-Year Return -93.38%
5-Year Return -99.13%
5-Year Revenue Growth -99.98%
5-Year Earnings Growth -105.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/13/19
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year 93.10%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 09/23/16

FCRE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.94%
Return-on-Assets % -9.42%
Profit Margin % -5,100.00%
Debt/Equity 0.00
Price/Sales 1,802.22
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 0.14
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar